ESC 365 - Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure

ESC Premium Access

Quantifying inflammation using interleukin-6 for improved phenotyping and risk stratification in acute heart failure

Session: Novel Biomarkers for Early Risk Stratification in Acute Heart Failure

Topic: Biomarkers

Speaker: Doctor E. Michou (Basel, CH)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Eleni Michou

University Hospital Basel, Basel (Switzerland)

0 follower

3 more presentations in this session

State-of-the-art lecture in novel biomarkers for early risk stratification in acute heart failure.

Speaker: Professor A. Maisel (San Diego, US)

Growth differentiation factor-15 significantly improves prognostication of short-term mortality in acute settings

Speaker: Ms K. Cerlinskaite-Bajore (Vilnius, LT)

Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness

Speaker: Doctor J. Chew-Harris (Christchurch, NZ)

Access the full session

Novel Biomarkers for Early Risk Stratification in Acute Heart Failure

Speakers: Doctor E. Michou, Professor A. Maisel, Ms K. Cerlinskaite-Bajore, Doctor J. Chew-Harris

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources